2022-11-14T13:17:43-06:00 2021-12-31 953001179 WINDES INC PO BOX 87 LONG BEACH CA 908010087 990 2021-01-01 208730839 LUNG CANCER FOUNDATION OF AMERICA LUNG 5073541361 15 S FRANKLIN STREET NEW ULM MN 56073 DAVID STURGES FOUNDER & TREASURER 5073541361 2022-11-09 1 DAVID STURGES 999009999 DONITA M JOSEPH P00286656 5624351191 2022-11-02 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z JIM BARANSKI 15 S FRANKLIN STREET NEW ULM MN 56073 1324574 0 X N/A X 2007 MN THE MISSION OF LUNG CANCER FOUNDATION OF AMERICA (LCFA) IS THE DRAMATIC IMPROVEMENT IN SURVIVORSHIP OF LUNG CANCER PATIENTS THROUGH THE FUNDING OF TRANSFORMATIVE SCIENCE, WITH THE ULTIMATE GOAL OF CURING THE DISEASE. TO ACCOMPLISH THIS, LCFA HAS WORKED TO RAISE BOTH THE FUNDS AND THE NATIONAL PROFILE OF LUNG CANCER IN ORDER TO SUBSTANTIALLY INCREASE SUPPORT OF INNOVATIVE AND GROUNDBREAKING RESEARCH EFFORTS. 11 9 4 121 0 0 1431119 1297921 0 0 1720 414 0 0 1432839 1298335 600000 210000 0 0 254370 401376 0 0 215013 497159 478334 1351529 1089710 81310 208625 1558916 1303793 908094 444346 650822 859447 X LCFA'S MISSION IS THE IMPROVEMENT IN SURVIVORSHIP OF LUNG CANCER PATIENTS THROUGH THE FUNDING OF TRANSFORMATIVE SCIENCE. WHILE RAISING FUNDS TO SUPPORT LUNG CANCER RESEARCH, LCFA WILL RAISE THE PUBLIC'S AWARENESS AND SERVE AS A RESOURCE FOR PATIENTS OR ANYONE SEEKING ANSWERS, HOPE, AND ACCESS TO UPDATED TREATMENT INFORMATION, SCIENTIFIC INVESTIGATION, AND CLINICAL TRIALS. 0 0 210000 210000 YOUNG INVESTIGATOR LUNG CANCER RESEARCH GRANTS 303215 LUNG CANCER PUBLIC AWARENESS 303214 PATIENT EDUCATION 816429 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 1 0 1 0 0 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 6 0 1 4 1 0 0 0 0 0 0 0 0 0 0 0 0 X 11 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AR AK CA CO CT DE FL GA HI ID IL IN IA KS KY LA MN MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X X GINA CRUZ 5073541361 15 S FRANKLIN STREET NEW ULM MN 56073 KIM NORRIS PRESIDENT 40.00 X X 87000 0 5309 DAVID STURGES TREASURER 10.00 X X 0 0 0 SUSAN MANDEL MD SECRETARY 10.00 X X 0 0 0 MARTA KAUFFMAN DIRECTOR 1.00 X 0 0 0 ROBERT FIGLIN MD FACP DIRECTOR 1.00 X 0 0 0 DAVID T LEVINSON DIRECTOR 1.00 X 0 0 0 MARTIN EDELMAN DIRECTOR 1.00 X 0 0 0 CAROLYN ZAINER DIRECTOR 1.00 X 0 0 0 MICHELLE SAYER DIRECTOR 1.00 X 0 0 0 JIM BARANSKI EXECUTIVE DIRECTOR 40.00 X X 174000 0 16110 TRISH COURY DIRECTOR 1.00 X 0 0 0 261000 0 21419 1 0 1 0 M&C COMMUNICATIONS 6464 S QUEBEC STREET 200 CENTENNIAL CO 80111 COMMUNICATION SERVICES 215975 1 6822 23823 1267276 17173 1297921 414 414 26239 23823 26239 0 1298335 0 0 414 X 10000 10000 200000 200000 282418 141462 28292 112664 93210 46605 9321 37284 25748 12874 2575 10299 32644 16422 3284 12938 420440 380378 670 39392 8018 4026 3716 276 2212 2212 1002 1002 223 223 2114 2114 OTHER EXPENSES 11681 3437 6084 2160 1089710 816429 58268 215013 328269 595486 644392 259453 578200 444132 8055 4722 1558916 1303793 33094 44346 875000 400000 908094 444346 X 235885 229716 414937 629731 650822 859447 1558916 1303793 208625 0 X 0 1 X 1 0 X 844482 1359997 1005221 1431119 1297921 5938740 844482 1359997 1005221 1431119 1297921 5938740 2971961 2966779 1389 2117 6302 1720 414 11942 5950682 0.49860 0.49510 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 1298335 0 1298335 0 1298335 1089710 0 1089710 0 1089710 PART X, LINE 2: FIN 48: THE FOUNDATION HAS RECEIVED TAX-EXEMPT STATUS FROM THE INTERNAL REVENUE SERVICE UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE FOUNDATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS ITS POSITION OF BEING TAX EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE FOUNDATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL AND STATE PURPOSES IS GENERALLY THREE AND FOUR YEARS, RESPECTIVELY. 1 NORTH AMERICA 0 0 PROGRAM SERVICES GRANTMAKING 200000 0 0 0 0 0 0 200000 0 200000 YOUNG INVESTIGATOR LUNG CANCER RESEARCH GRANT NORTH AMERICA 1 200000 WIRE 0 0 0 0 0 0 PART I, LINE 2: GRANT RECIPIENTS MUST PROVIDE THE FOLLOWING INFORMATION FOR CONSIDERATION: - PLANNED SPECIFIC AIMS. - RATIONALE FOR THE PROJECT TOGETHER WITH BACKGROUND, SIGNIFICANCE AND INNOVATION OF PROPOSAL. - BRIEF STATEMENT OF THE OVERALL EXPERIMENTAL APPROACH. - BRIEF STATEMENT DESCRIBING THE CLINICAL CONTEXT IN WHICH THE BIOMARKER OR RESEARCH PROJECT WILL BE USED AND THE QUANTITATIVE PERFORMANCE THAT YOUR BIOMARKER SHOULD ACHIEVE TO SHOW CLINICAL UTILITY. - NIH BIOSKETCH OF THE APPLICANT(S) BUDGET, INCLUDING PERSONNEL, SUPPLIES, PUBLICATION COSTS, TRAVEL, CLINICAL TRIAL COSTS, ANIMAL COSTS. PART I, LINE 3: THE ACCRUAL METHOD OF ACCOUNTING IS USED TO REPORT THESE EXPENDITURES. PART III ACCOUNTING METHOD: DAY AT THE CHEF'S TABLE 50062 23823 26239 26239 50062 23823 26239 26239 26239 0 1 YOUNG INVESTIGATOR LUNG CANCER RESEARCH GRANT 1 10000 PART I, LINE 2: DESCRIBE THE ORGANIZATION'S PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS IN THE UNITED STATES: GRANT RECIPIENTS MUST PROVIDE THE FOLLOWING INFORMATION FOR CONSIDERATION: - PLANNED SPECIFIC AIMS. - RATIONALE FOR THE PROJECT TOGETHER WITH BACKGROUND, SIGNIFICANCE AND INNOVATION OF PROPOSAL. - BRIEF STATEMENT OF THE OVERALL EXPERIMENTAL APPROACH. - BRIEF STATEMENT DESCRIBING THE CLINICAL CONTEXT IN WHICH THE BIOMARKER OR RESEARCH PROJECT WILL BE USED AND THE QUANTITATIVE PERFORMANCE THAT YOUR BIOMARKER SHOULD ACHIEVE TO SHOW CLINICAL UTILITY. - NIH BIOSKETCH OF THE APPLICANT(S) BUDGET, INCLUDING PERSONNEL, SUPPLIES, PUBLICATION COSTS, TRAVEL, CLINICAL TRIAL COSTS, ANIMAL COSTS. X X X X X 0 0 0 0 0 0 0 0 0 JIM BARANSKI EXECUTIVE DIRECTOR 174000 0 0 0 0 0 0 0 16110 0 190110 0 0 0 JULIE LEVINSON SISTER OF BOARD MEMBER DAVID T. LEVINSON. 18000 FREELANCE COPYWRITER 0 FORM 990, PART VI, SECTION B, LINE 11B DESCRIBE THE PROCESS USED BY THE ORGANIZATION TO REVIEW THIS FORM 990: THE DRAFT FORM 990 IS REVIEWED BY THE LCFA CORPORATE OFFICERS, AND THEN SUBMITTED TO THE LCFA BOARD OF DIRECTORS FOR REVIEW AND COMMENT. FORM 990, PART VI, SECTION B, LINE 12C DID THE ORGANIZATION REGULARLY AND CONSISTENTLY MONITOR THE CONFLICT OF INTEREST POLICY? LCFA'S CONFLICT OF INTEREST POLICY IS REVIEWED ANNUALLY AND EACH DIRECTOR, OFFICER AND SENIOR STAFF MEMBER WILL CERTIFY ANNUALLY THAT HE OR SHE HAS RECEIVED, READ, UNDERSTOOD AND IS IN COMPLIANCE WITH, THE POLICY. IT IS THE RESPONSIBILITY OF EACH OFFICER AND DIRECTOR OF THE CORPORATION TO DISCHARGE HIS OR HER DUTIES AS A DIRECTOR AND OFFICER IN GOOD FAITH, IN A MANNER THE PERSON REASONABLY BELIEVES TO BE IN THE BEST INTERESTS OF THE CORPORATION, AND WITH THE CARE AN ORDINARILY PRUDENT PERSON IN A LIKE POSITION WOULD EXERCISE UNDER SIMILAR CIRCUMSTANCES. FORM 990, PART VI, SECTION B, LINE 15 DID THE PROCESS TO DETERMINE COMPENSATION INCLUDE A REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABLE DATA AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION? LCFA IS REGULARLY AND CONSISTENTLY MONITORING THE PERFORMANCE AND SALARY OF THE EXECUTIVE DIRECTOR, OTHER OFFICERS, AND KEY EMPLOYEES. LCFA UTILIZED A COMPENSATION STUDY AND A COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 DESCRIBE HOW THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMETNS AVAILABLE TO THE PUBLIC: LCFA MAKES ALL GOVERNING DOCUMENTS AND FINANCIAL INFORMATION AVAILABLE TO THE PUBLIC ON REQUEST. FORM 990, PART IX, LINE 11G EDUCATION AWARENESS: PROGRAM SERVICE EXPENSES 331,776. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 331,776. PATIENT EDUCATION: PROGRAM SERVICE EXPENSES 23,690. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 23,690. SPEAKERS BUREAU: PROGRAM SERVICE EXPENSES 18,174. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 18,174. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 490. FUNDRAISING EXPENSES 21,600. TOTAL EXPENSES 22,090. PROFESSIONAL COMPLIANCE FEES: PROGRAM SERVICE EXPENSES 6,738. MANAGEMENT AND GENERAL EXPENSES 180. FUNDRAISING EXPENSES 17,792. TOTAL EXPENSES 24,710.